Sai Life Sciences Limited (NSE:SAILIFE)
India · Delayed Price · Currency is INR 876.80
-16.45 (-1.84%)
At close: Aug 12, 2025, 3:30 PM IST
Sai Life Sciences Revenue
Sai Life Sciences had revenue of 4.96B INR in the quarter ending June 30, 2025, with 77.47% growth. This brings the company's revenue in the last twelve months to 19.11B, up 34.24% year-over-year. In the fiscal year ending March 31, 2025, Sai Life Sciences had annual revenue of 16.95B with 15.66% growth.
Revenue (ttm)
19.11B
Revenue Growth
+34.24%
P/S Ratio
9.76
Revenue / Employee
6.10M
Employees
2,845
Market Cap
186.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 16.95B | 2.29B | 15.66% |
| Mar 31, 2024 | 14.65B | 2.48B | 20.38% |
| Mar 31, 2023 | 12.17B | 3.48B | 39.97% |
| Mar 31, 2022 | 8.70B | 1.10B | 14.44% |
| Mar 31, 2021 | 7.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 96.52B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 232.42B |
| Fortis Healthcare | 80.94B |
| Aurobindo Pharma | 320.25B |